Pliant Therapeutics

Pliant Therapeutics' Drug Trial Shows Promise In Reversing Lung Fibrosis In Patients
Benzinga
Tue, 05/14/24 - 11:44 am
Pliant Therapeutics
clinical trials
bexotegrast
IPF
Novartis backs away from NASH, furthering its research revamp
BioPharma Dive
Sun, 02/26/23 - 10:16 pm
Novartis
NASH
Pliant Therapeutics
PLN-1474
Promising IPF treatment results sent Pliant Therapeutics stock soaring
Investors Business Daily
Tue, 01/24/23 - 10:28 am
Pliant Therapeutics
clinical trials
IPF
bexotegrast
Catalysts ahead for the smaller players
EP Vantage
Wed, 12/21/22 - 11:19 am
89Bio
Altimmune
AnaptysBio
BioXcel Therapeutics
Calliditas Therapeutics
Eli Lilly
Esperion Therapeutics
Geron
Nektar Therapeutics
Oramed Pharmaceuticals
Pliant Therapeutics
Replimune
Selecta Biosciences
Swedish Orphan Biovitrum
Vera Therapeutics
Viking Therapeutics
Pliant Therapeutics Announces Pricing of Upsized $200.0 Million Public Offering
BioSpace
Tue, 07/12/22 - 11:36 pm
Pliant Therapeutics
IPOs
With new data, Pliant drug shows promise in tough-to-treat lung disease
BioPharma Dive
Mon, 07/11/22 - 10:28 am
Pliant Therapeutics
idiopathic pulmonary fibrosis
IPF
PLN-74809
clinical trials
The lung fibrosis pipeline thins
EP Vantage
Tue, 09/21/21 - 10:48 am
idiopathic pulmonary fibrosis
IPF
Pliant Therapeutics
PLN-74809
What pandemic? Biotech floats break records
EP Vantage
Wed, 07/8/20 - 10:37 am
biotech
IPOs
ADC Therapeutics
Akouos
Applied Molecular Transport
Avidity Biosciences
Ayala Pharmaceuticals
Forma Therapeutics
Fusion Pharmaceuticals
Generation Bio
Hyloris Pharmaceuticals
Lantern Pharma
ORIC Pharmaceuticals
Pliant Therapeutics
PolyPid
Repare Therapeutics
Royalty Pharma
SutroVax
Could This Recent IPO Biotech Become the Next Moderna?
Motley Fool
Sat, 06/13/20 - 11:37 pm
Pliant Therapeutics
IPOs
Moderna Therapeutics
fibrotic disease
Biotech IPOs near last year's pace, despite COVID-19 pandemic
BioPharma Dive
Wed, 06/3/20 - 11:28 pm
IPOs
biotech
Pliant Therapeutics
Legend Biotech
With money flowing, Pliant Therapeutics heads to public well
Endpoints
Tue, 05/12/20 - 11:56 am
IPOs
Pliant Therapeutics
Rare Diseases
oncology
With one rival down, Novartis-partnered biotech scores $100M round to fund mid-stage trials of fibrosis drug
Endpoints
Tue, 03/3/20 - 11:02 am
Pliant Therapeutics
IPF
Biogen
Novartis
Novartis bets $80M on Pliant's preclinical NASH prospect
Fierce Biotech
Wed, 10/23/19 - 10:39 pm
Novartis
NASH
Pliant Therapeutics
PLN-1474
Chasing Biogen, the Pliant crew banks a $62M round to fuel their shot at fibrosis targets
Endpoints
Mon, 07/16/18 - 09:57 am
Pliant Therapeutics
IPF
idiopathic pulmonary fibrosis
Drugs to Halt, or Reverse, Deadly Lung Scarring? Third Rock Bets $45M it Can Be Done
Forbes
Thu, 02/18/16 - 09:48 am
Third Rock
idiopathic pulmonary fibrosis
Pliant Therapeutics